欢迎来到南通科瑞斯生物医药科技有限公司官网!

新闻中心

热门关键词

联系我们

科瑞斯·总部

电话:0513-68015200

邮箱:infor@pharmacorelab.com

地址:江苏省海门市临江新区海门生物医药科技创业园



行业新闻

您的当前位置: 首页 > 新闻动态 > 行业新闻

Reaction Biology and PharmaCore Labs Announce China Outreach

发布日期:2020-04-23 15:10:00 作者:本站 点击:208

MALVERN, Pa. and HAIMEN, China, April 23, 2020 /PRNewswire/ -- Reaction Biology Corp. ("RBC"), a US-based preclinical CRO with offices in Pennsylvania and Germany, and PharmaCore Labs (PCL) Co., Ltd, a Chinese firm with offices in Haimen, China, today announced a joint collaboration agreement in China. Under the terms of the agreement, PCL will supply business support and development personnel to RBC, as well as a staging facility for compound transshipment to the US. RBC will make its full suite of biochemical, cell, and in vivo assay services available to PCL for distribution in China.  The arrangement is designed to make it more convenient for Chinese firms to use RBC's services, and also allows RBC to invoice in yuan. https://www.biospace.com/article/releases/reaction-biology-and-pharmacore-labs-announce-china-outreach/

Copyright © 南通科瑞斯生物医药科技有限公司 All rights reserved 备案号:苏ICP备15051795号 欢迎来电咨询! 技术支持:裕福科技